Adial Pharmaceuticals ADIL Chief Strategy Officer · filings 2026 to 2026
No transactions in the filings read; Form 144 notices are listed above.
Chief Strategy Officer at Adial Pharmaceuticals
As reported after the latest Form 3, 4 or 5 at each company.
Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.
| Company | Security | Held | Shares or units | As of |
|---|---|---|---|---|
| Adial Pharmaceuticals ADIL | Common Stock | Directly | 62,665 | Oct 28, 2026 · Filing · EDGAR |
| Adial Pharmaceuticals ADIL | Series A Preferred Stock into Common Stock | Directly | 1,852,229 | Oct 28, 2026 · Filing · EDGAR |
| Adial Pharmaceuticals ADIL | Stock Option (right to buy) exercise $2.98, expires Jun 12, 2036, into Common Stock | Directly | 72,719 | Oct 28, 2026 · Filing · EDGAR |
| Adial Pharmaceuticals ADIL | Stock Option (Right to Buy) exercise $0.63, expires Apr 20, 2036, into Common Stock | Directly | 67,021 | Oct 28, 2026 · Filing · EDGAR |
| Adial Pharmaceuticals ADIL | Stock Option (Right to Buy) exercise $1.57, expires Nov 21, 2033, into Common Stock | Directly | 31,915 | Oct 28, 2026 · Filing · EDGAR |
No sales or Form 144 notices with a stated value.
Each Form 3, 4 and 5 transaction in plain words, newest first.
Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.
No transactions in the filings read; Form 144 notices are listed above.
| Filed | Form | Company | Links |
|---|---|---|---|
| Oct 30, 2026 | Form 3 | Adial Pharmaceuticals ADIL | Filing · EDGAR |
Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.